| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 20/05/2021 | 13:16 | InvestorsHub NewsWire | Lexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..cont | CSE:LXX | Lexaria Bioscience Corp |
| 22/04/2021 | 13:30 | InvestorsHub NewsWire | Lexaria Commences Human Clinical Hypertension Study | CSE:LXX | Lexaria Bioscience Corp |
| 14/04/2021 | 13:37 | InvestorsHub NewsWire | Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network | CSE:LXX | Lexaria Bioscience Corp |
| 06/04/2021 | 13:16 | InvestorsHub NewsWire | Lexaria to Evaluate DehydraTECHTM in Multiple New Markets | CSE:LXX | Lexaria Bioscience Corp |
| 24/03/2021 | 13:00 | InvestorsHub NewsWire | Lexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD Beverages | CSE:LXX | Lexaria Bioscience Corp |
| 10/03/2021 | 17:54 | InvestorsHub NewsWire | Could DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria? | CSE:LXX | Lexaria Bioscience Corp |
| 27/01/2021 | 14:00 | InvestorsHub NewsWire | CANNABIS INVESTING - Khiron (KHRNF) & Lexaria (LEXX) with Ted Ohashi | CSE:LXX | Lexaria Bioscience Corp |
| 16/12/2020 | 16:00 | InvestorsHub NewsWire | CANNABIS INVESTING - Cannabis News, Khiron, & Lexaria Bioscience | CSE:LXX | Lexaria Bioscience Corp |
| 01/12/2020 | 12:41 | InvestorsHub NewsWire | Lexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs | CSE:LXX | Lexaria Bioscience Corp |
| 04/09/2019 | 14:45 | InvestorWire | Innovative Drug-Delivery Systems Benefit Patients and Businesses | CSE:LXX | Lexaria Bioscience Corp |
| 11/06/2019 | 14:45 | InvestorWire | Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments | CSE:LXX | Lexaria Bioscience Corp |
| 29/05/2019 | 14:45 | InvestorWire | Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles | CSE:LXX | Lexaria Bioscience Corp |
| 30/01/2019 | 14:45 | InvestorWire | Outside Investment, New Technology Support Growing Cannabis Industry | CSE:LXX | Lexaria Bioscience Corp |
| 16/01/2019 | 14:45 | InvestorWire | Definitive Agreement Marks Milestone for Alternative Nicotine Delivery Options | CSE:LXX | Lexaria Bioscience Corp |
| 28/11/2018 | 14:45 | InvestorWire | Booming Cannabis Consumables Space Continues to see Product Innovations | CSE:LXX | Lexaria Bioscience Corp |
| 22/10/2018 | 14:45 | InvestorWire | Canada Leads International Cannabis Boom — and It’s Not About Smoking | CSE:LXX | Lexaria Bioscience Corp |
| 04/10/2018 | 14:45 | InvestorWire | Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector | CSE:LXX | Lexaria Bioscience Corp |
| 15/08/2018 | 14:45 | InvestorWire | Big Businesses Look for Healthier Alternatives to Smoking for Drug Delivery | CSE:LXX | Lexaria Bioscience Corp |
| 24/04/2018 | 14:45 | InvestorWire | Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors | CSE:LXX | Lexaria Bioscience Corp |
| 03/04/2018 | 14:45 | InvestorWire | Cannabis Biotech Booms | CSE:LXX | Lexaria Bioscience Corp |
| 06/02/2018 | 14:45 | InvestorWire | Cannabis Deals Cross the Billion-Dollar Mark in Canada | CSE:LXX | Lexaria Bioscience Corp |
| 09/01/2018 | 14:45 | InvestorWire | Intriguing Research into Pathways to Limit Nicotine, Quit Cigarette Use | CSE:LXX | Lexaria Bioscience Corp |
| 09/11/2017 | 16:12 | InvestorsHub NewsWire | Lexaria Bioscience Files Innovative New Patent Application | CSE:LXX | Lexaria Bioscience Corp |
| 02/11/2017 | 13:45 | InvestorWire | Bioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, Medication | CSE:LXX | Lexaria Bioscience Corp |
| 01/11/2017 | 14:32 | InvestorsHub NewsWire | Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, and Nicotine ... | CSE:LXX | Lexaria Bioscience Corp |
| 19/09/2017 | 14:45 | InvestorWire | Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects | CSE:LXX | Lexaria Bioscience Corp |
| 06/09/2017 | 14:45 | InvestorWire | Landmark M&A Deals Continue to Shape Big Pharma | CSE:LXX | Lexaria Bioscience Corp |
| 16/08/2017 | 14:45 | InvestorWire | FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators | CSE:LXX | Lexaria Bioscience Corp |
| 27/07/2017 | 14:45 | InvestorWire | Biotech Players Lead the Growth Charge in the Legal Cannabis Market | CSE:LXX | Lexaria Bioscience Corp |
| 19/01/2017 | 15:11 | InvestorsHub NewsWire | LEXARIA AND NEUTRISCI ANNOUNCE SUCCESSFUL CANNABINOID TABLET DEVELOPMENT AND POSITIVE RESULTS | CSE:LXX | Lexaria Bioscience Corp |